Airline Industry Today
SEE OTHER BRANDS

Fresh airlines and aviation news from the world

Airline Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Airline Industry Today.

Press releases published on July 8, 2025

Coralogix Signs Strategic Collaboration Agreement with AWS to Advance AI-Powered Observability and Security

Coralogix Signs Strategic Collaboration Agreement with AWS to Advance AI-Powered Observability and Security

BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Coralogix, a leading full-stack observability platform provider, today announced a strategic collaboration agreement (SCA) with Amazon Web Services (AWS). Through this collaboration, Coralogix and AWS will create …

Enphase Energy Announces Conference Call to Review Second Quarter 2025 Financial Results

Enphase Energy Announces Conference Call to Review Second Quarter 2025 Financial Results

FREMONT, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, announced today that it will host a conference …

Marotta Controls Maintains Top Workplace Honors in New Jersey and Across the United States

Marotta Controls Maintains Top Workplace Honors in New Jersey and Across the United States

MONTVILLE, N.J., July 08, 2025 (GLOBE NEWSWIRE) -- Marotta Controls, a rapidly growing aerospace and defense supplier, today announced that it has once again been named a Top Workplace by both NJ.com and USA TODAY in partnership with Energage. This marks …

OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress

OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress

MIAMI and JERUSALEM, July 08, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (“OPKO”) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that their abstract “First-in-Class Oral GLP-2 Analog for Treatment of Short Bowel Syndrome” has …

Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency

Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency

DURHAM, N.C., July 08, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced today that Symvess has been …

RTI and Kinova Partner to Integrate Intelligent Connectivity into Medical Robotics

RTI and Kinova Partner to Integrate Intelligent Connectivity into Medical Robotics

SUNNYVALE, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Real-Time Innovations (RTI), the software framework company for physical AI systems, today announced its partnership with Kinova, a global leader in professional and medical robotics. This collaboration …

Sustainably-Focused WinCup Acquires Paper Cup Manufacturing Capabilities of ConverPack Inc.

Sustainably-Focused WinCup Acquires Paper Cup Manufacturing Capabilities of ConverPack Inc.

ATLANTA, July 08, 2025 (GLOBE NEWSWIRE) -- WinCup, Inc., a leading national manufacturer of disposable foodservice products, announced today that it has acquired the paper cup company ConverPack Inc., a global manufacturer of hot and cold paper cups, in a …

Certara Announces Expansion of Clinical Technology Collaboration with Merck

Certara Announces Expansion of Clinical Technology Collaboration with Merck

RADNOR, Pa., July 08, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced a new collaboration with Merck, known as MSD outside of the United States and Canada, that expands Merck’s use …

Quantum BioPharma Submits its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in the United Kingdom

Quantum BioPharma Submits its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in the United Kingdom

TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today …

Vaxart Announces Trading on OTCQX Best Market

Vaxart Announces Trading on OTCQX Best Market

SOUTH SAN FRANCISCO, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform,  …

Akebia Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference

Akebia Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference

CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that Nik Grund, Chief Commercial Officer, …

Amaero Announces Velo3D Qualification Condition Satisfied for C103 and Ti64

Amaero Announces Velo3D Qualification Condition Satisfied for C103 and Ti64

~ Enters into Technical Development Collaboration with Aurburn University ~ MCDONALD, Tenn., July 08, 2025 (GLOBE NEWSWIRE) -- Amaero Ltd (ASX:3DA) (OTCQB: AMROF) (“Amaero” or the “Company”), a leading U.S. domestic producer of high-value C103, refractory …

Treatment.com AI Announces Momentum Following Acquisition of Rocket Doctor, Highlighting Growth, Innovation, and National Recognition

Treatment.com AI Announces Momentum Following Acquisition of Rocket Doctor, Highlighting Growth, Innovation, and National Recognition

Treatment.com AI completed the acquisition of Rocket Doctor, aligning AI-powered clinical intelligence with a proven virtual care delivery platform.‏ Rocket Doctor patient volume grew 112% in Alberta year-over-year, with over 36,000 patients seen in 2024 …

Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia

Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia

Salt Lake City, UT, July 08, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives today announced the acquisition of Rallybio’s (NASDAQ: RLYB) full interest in their joint …

Sonoco Achieves Prestigious Pet Sustainability Coalition (PSC) Accreditation

Sonoco Achieves Prestigious Pet Sustainability Coalition (PSC) Accreditation

HARTSVILLE, S.C., July 08, 2025 (GLOBE NEWSWIRE) -- Sonoco Products Company (NYSE: SON), a global leader in value-added sustainable packaging, today announced it has earned accreditation with the Pet Sustainability Coalition (PSC). Sonoco joined PSC in …

BD² AND BRAIN CANADA ANNOUNCE PARTNERSHIP AND NEW INTERNATIONAL SITE TO JOIN LANDMARK BIPOLAR DISORDER RESEARCH NETWORK

BD² AND BRAIN CANADA ANNOUNCE PARTNERSHIP AND NEW INTERNATIONAL SITE TO JOIN LANDMARK BIPOLAR DISORDER RESEARCH NETWORK

Washington, D.C, July 08, 2025 (GLOBE NEWSWIRE) -- Today, Breakthrough Discoveries for thriving with Bipolar Disorder (BD²) and Brain Canada announced an international partnership to advance research and transform care for people living with bipolar …

Enterprises Enhance Privacy, Security and Control with Rackspace Technology’s OpenStack Business Private Cloud

Enterprises Enhance Privacy, Security and Control with Rackspace Technology’s OpenStack Business Private Cloud

SAN ANTONIO, July 08, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a leading end-to-end hybrid cloud and AI solutions company, today announced the launch of Rackspace OpenStack Business, a new, open source, dedicated private cloud for …

Beacon Therapeutics completes enrollment in registrational Phase 2/3 VISTA trial of laru-zova for patients with XLRP

Beacon Therapeutics completes enrollment in registrational Phase 2/3 VISTA trial of laru-zova for patients with XLRP

Topline data expected in H2 2026 LONDON and CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (“Beacon Therapeutics” or ”the Company”), a leading clinical-stage biotechnology company with a mission to save and restore …

Maxus Mining Announces Appointment of Morgan Verge as Technical Advisor

Maxus Mining Announces Appointment of Morgan Verge as Technical Advisor

VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce the appointment of Morgan Verge as a Technical Advisor to the Company (the “Appointment”). Ms. Verge …

TFI International to Release 2025 Second Quarter Results

TFI International to Release 2025 Second Quarter Results

MONTREAL, July 08, 2025 (GLOBE NEWSWIRE) -- TFI International Inc. (NYSE and TSX: TFII), a North American leader in the transportation and logistics industry, today announced that it will release its financial results for the second quarter ended June 30, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions